Mereo BioPharma Group plc
MREO
$0.32
$0.013.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.24% | -30.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.84% | -22.82% | |||
| Operating Income | -13.84% | 22.82% | |||
| Income Before Tax | 8.60% | -4.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.60% | -4.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.60% | -4.66% | |||
| EBIT | -13.84% | 22.82% | |||
| EBITDA | -18.76% | 27.08% | |||
| EPS Basic | 8.71% | -4.56% | |||
| Normalized Basic EPS | 8.71% | -4.74% | |||
| EPS Diluted | 8.71% | -4.56% | |||
| Normalized Diluted EPS | 8.71% | -4.74% | |||
| Average Basic Shares Outstanding | 0.17% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||